Track topics on Twitter Track topics that are important to you
Bayer AG said late Monday that investment company Temasek has signed an agreement to increase its share capital in the German company. Temasek has subscribed to 31 million new Bayer shares, which equals around 3.6 percent of Bayer's capital stock, for 3 billion euros in total gross proceeds, Bayer said.
Original Article: Bayer shareholder Temasek to boost share capitalNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...